Alexa
  • Directory of Taiwan

Chinese court stiff on Viagra trademark infringements

Chinese court stiff on Viagra trademark infringements

A Chinese court has upheld the validity of drug maker Pfizer Inc.'s patent for Viagra, ordering two companies to stop sales of generic versions of the erectile dysfunction treatment and pay compensation for trademark infringements, a court official stated yesterday.
The Beijing No. 1 Intermediate People's Court ordered Beijing Health New Concept Pharmacy Co. to stop sales of blue pills similar to Viagra, according to a court official who gave only his surname, Wang.
The court told Lianhuan Pharmaceutical Co., based in eastern China's Jiangsu province, to stop making the pills and to pay Pfizer 300,000 yuan (US$38,000) in damages, Wang said, confirming a report by the official Xinhua News Agency.
Pfizer sued Lianhuan and Beijing Health New Concept in September 2005. It also sued Guangzhou Viaman Pharmaceutical Co., which produced another anti-impotence drug registered as "Weige" in 1998, Xinhua said.
However, the court rejected Pfizer's claim that Viaman had instigated the two companies to violate its patent and trademark, it said.
In June, the same court sided with Pfizer in overturning a 2004 decision by China's patent review board in ruling against local drug makers keen to sell their own generic versions of Viagra in China.


Updated : 2021-07-31 11:47 GMT+08:00